I agree that this site is using cookies. You can find further informations here.
X
Pearson, Isobel
65  results:
Search for persons X
?
1

A Systematic Review of Clinical Practice Guidelines for Alz..:

Tahami Monfared, Amir Abbas ; Phan, N. T. Nhan ; Pearson, Isobel...
Neurology and Therapy.  12 (2023)  4 - p. 1257-1284 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L. ; Zhang, Yuanhui...
PharmacoEconomics.  40 (2021)  3 - p. 323-339 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Targeted literature review on use of tumor mutational burde..:

Krieger, Tina ; Pearson, Isobel ; Bell, Judith..
Diagnostic Pathology.  15 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
4

Economic Modeling Considerations for Rare Diseases:

Pearson, Isobel ; Rothwell, Ben ; Olaye, Andrew.
Value in Health.  21 (2018)  5 - p. 515-524 , 2018
Link: https://doi.org/10.1016/..
 
?
5

A cost-effectiveness analysis using real-world data from th..:

Herring, William ; Zhang, Yuanhui ; Pearson, Isobel...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
6

Cost Effectiveness of Ofatumumab Plus Chlorambucil in First..:

Herring, William ; Pearson, Isobel ; Purser, Molly...
PharmacoEconomics.  34 (2015)  1 - p. 77-90 , 2015
Link: https://doi.org/10.1007/..
 
?
7

Erratum to: Cost-effectiveness of febuxostat in chronic gou:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  15 (2014)  8 - p. 897-897 , 2014
Link: https://doi.org/10.1007/..
 
?
8

Cost-effectiveness of febuxostat in chronic gout:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  15 (2014)  5 - p. 453-463 , 2014
Link: https://www.jstor.org/st..
 
?
9

Cost-effectiveness of febuxostat in chronic gout:

Beard, Stephen M. ; von Scheele, Birgitta G. ; Nuki, George.
The European Journal of Health Economics.  , 2013
Link: https://doi.org/10.1007/..
 
?
10

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L ; Zhang, Yuanhui...
boreal:261915.  , 2022
Link: http://hdl.handle.net/20..
 
?
11

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L ; Zhang, Yuanhui...
boreal:261915.  , 2022
Link: http://hdl.handle.net/20..
 
?
12

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L ; Zhang, Yuanhui...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866337/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L ; Zhang, Yuanhui...
http://hdl.handle.net/10668/21696.  , 2021
Link: http://hdl.handle.net/10..
 
?
14

Comparative Effectiveness and Cost-Effectiveness of Nataliz..:

Spelman, Timothy ; Herring, William L ; Zhang, Yuanhui...
info:eu-repo/semantics/altIdentifier/wos/WOS:000731206500001.  , 2021
Link: http://hdl.handle.net/11..
 
?
15

A Mutant of Paracoccus denitrificans with Disrupted Genes C..:

Pearson, Isobel V ; Page, M. Dudley ; van Spanning, Rob J. M.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC219389.  , 2003
Link: http://www.ncbi.nlm.nih...
 
1-15